Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › BAYERCROP

BAYERCROP

Bayer Cropscience Limited
Small-capChemicals ↗

What the six lenses say about BAYERCROP — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹3987.4
2026-09-08
VWAP · 1Y anchor
₹4518
-11.7% from VWAP
P/E · TTM
628.9×
TTM EPS ₹6.3
52-week range
2%
position low→high
RSI(14)
37
momentum

Own sector index

Chemicals ↗
Neutral

1M

-2.7%

3M

+4.7%

1Y

—

Breadth >EMA21

40%

How BAYERCROP’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
2.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD28›

The actual numbers

Price vs VWAP (1y)-11.7%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-10.7%
Price vs 50-EMA-3.7%
RSI(14)37
RS vs Nifty 500 · 3M-11.4%
RS vs sector · 3M-11.6%
52-week range2%
Volume vs 30d avg0.44×
Volume vs 60d avg0.27×
ATR(14) · volatility69.5
Bollinger width · vol contraction0.049
FundamentalD444›

The actual numbers

Return on equity (ROE)15.8%
Return on capital (ROCE)20.1%
Net margin7.0%
Debt / equity0.34×

Full 8-quarter history in the financials table below.

ValuationD850›

The actual numbers

P/E (TTM)628.9×
TTM EPS₹6.3
52-week range2%
Catalyst——›

Every filing in the corporate-announcements panel below.

FlowD342›

The actual numbers

Promoter holding68.7%
Delivery · 30d avg60.4%
Up/down-day asymmetry-3.9pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D3 ) ÷ 2 = 2.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
11
Conviction score 11/100 · avg-decile strength 2.5/10
Conviction score11/100›
TechnicalD2›
FundamentalD4›
ValuationD8›
Catalyst
FlowD3›

Policy

Government policy · Chemicals

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Watch· MEDIUM impact

China+1 Manufacturing Shift

Supply-chain diversification away from China benefiting Indian chemical and component manufacturers

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.4pp
+1.7pp
-1.9pp
-9.8pp
-10.6pp
-17.1pp
Nifty 500
Broad-market baseline
+0.4pp
+1.7pp
-3.0pp
-11.4pp
-16.3pp
-22.4pp
Sector
Own-sector index
—
—
-2.7pp
-11.6pp
-22.5pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

BAYERCROP daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
3987.40-2.50

Relative strength

RS vs baseline · rebased to 100

BAYERCROP ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
64.50+0.23

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricDec '05Dec '06
Revenue (₹cr)223242
↳ change QoQ—+8.5%
EBITDA (₹cr)2918
EBITDA margin13.0%7.4%
PAT (₹cr)817
↳ change QoQ—+112.5%
Net margin3.6%7.0%
EPS (₹)1.974.37
D/E——
YoY growth · Dec '06Revenue n/aPAT n/a

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Oct '13
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

Ownership

Who holds BAYERCROP

Mutual funds holding BAYERCROP (10)

FundWeightAUM ₹crGrade
Quant Small Cap Gr1.29%34,069
DSP Small Cap Reg Gr1.21%20,221
DSP Multi Asset Allocation Reg Gr0.78%10,592
Bandhan Flexi Cap Gr0.50%7,575
Bandhan ELSS Tax saver Reg Gr1.07%7,005
Bandhan Multi Cap Reg Gr0.90%3,064
DSP Multicap Reg Gr1.25%2,998
Tata India Pharma & Healthcare Reg Gr3.26%1,541
Bank of India Multi Cap Reg Gr0.97%1,259
Bank of India Manfactrg & Infra Gr1.24%893

ETFs holding BAYERCROP (1)

ETFWeightGrade
Kotak Nifty Chemicals ETF1.44%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Chemicals